A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
Clinical trial NCT04774718 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04774718
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-14
- Primary completion
- 2032-02-28
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.